Drug-regulated CD33-targeted CAR T Cells Control AML Using Clinically Optimized Rapamycin Dosing
Jacob Appelbaum,April E. Price,Kaori Oda,Joy Zhang,Wai-Hang Leung,Giacomo Tampella,Dong Xia,Pauline P. L. So, Sarah K. Hilton,Claudya Evandy, Semanti Sarkar,Unja Martin,Anne-Rachel Krostag, Marissa Leonardi,Daniel E. Zak, Rachael Logan, Paula Lewis, Secil Franke-Welch, Njabulo Ngwenyama, Michael Fitzgerald, Niklas Tulberg,Stephanie Rawlings-Rhea,Rebecca A. Gardner,Kyle Jones,Angelica Sanabria,William Crago,John Timmer,Andrew Hollands,Brendan Eckelman,Sanela Bilic, Jim Woodworth,Adam Lamble,Philip D. Gregory,Jordan Jarjour,Mark Pogson,Joshua A. Gustafson,Alexander Astrakhan,Michael C. Jensen JOURNAL OF CLINICAL INVESTIGATION（2024）
关键词
CAR T Cells,Chimeric Antigen Receptor,T Cell Therapy
AI 理解论文
溯源树
样例
